NCT02233751View on ClinicalTrials.gov

Pharmacokinetic Study of Subcutaneous Testosterone Enanthate

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Hypogonadism
Interventions
COMBINATION_PRODUCT

Testosterone enanthate auto-injector

Randomization then administration of combination product study medication according to group assignment

Trial Locations (1)

45227

Medpace Clinical Pharmacology Unit, Cincinnati

Sponsors
All Listed Sponsors
lead

Antares Pharma Inc.

INDUSTRY